Stockscreener 앱 받기
37.53
1.16%
0.43
시장 영업 전:
37.06
-0.47
-1.25%
전일 마감가:
$37.10
열려 있는:
$37.1
하루 거래량:
1.07M
Relative Volume:
1.81
시가총액:
$2.16B
수익:
$681.88M
순이익/손실:
$122.63M
주가수익비율:
17.79
EPS:
2.11
순현금흐름:
$220.18M
1주 성능:
-1.37%
1개월 성능:
+9.10%
6개월 성능:
+16.63%
1년 성능:
+3.25%
1일 변동 폭
$36.38
$37.59
1주일 범위
$36.38
$38.21
52주 변동 폭
$26.47
$41.61
하모니 바이오 Stock (HRMY) Company Profile
명칭
Harmony Biosciences Holdings Inc
전화
(484) 539-9800
주소
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
HRMY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
37.53 | 2.13B | 681.88M | 122.63M | 220.18M | 2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.62 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.80 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.43 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
722.01 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
336.26 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
하모니 바이오 Stock (HRMY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-21 | 개시 | Truist | Buy |
| 2025-07-10 | 재개 | Goldman | Neutral |
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-12-17 | 개시 | H.C. Wainwright | Buy |
| 2024-10-10 | 재개 | Raymond James | Outperform |
| 2024-09-10 | 개시 | UBS | Buy |
| 2024-06-21 | 개시 | Citigroup | Buy |
| 2024-01-02 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-09-25 | 다운그레이드 | Goldman | Neutral → Sell |
| 2023-09-07 | 개시 | Berenberg | Buy |
| 2023-04-20 | 개시 | BofA Securities | Neutral |
| 2022-10-14 | 업그레이드 | Janney | Neutral → Buy |
| 2022-10-14 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-08-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-07-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-07-07 | 개시 | Mizuho | Buy |
| 2022-04-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-12-01 | 개시 | Oppenheimer | Outperform |
| 2021-11-04 | 개시 | Raymond James | Outperform |
| 2021-09-23 | 개시 | Needham | Buy |
| 2021-03-29 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-09-14 | 개시 | Goldman | Neutral |
| 2020-09-14 | 개시 | Jefferies | Buy |
| 2020-09-14 | 개시 | Piper Sandler | Overweight |
모두보기
하모니 바이오 주식(HRMY)의 최신 뉴스
Published on: 2025-09-03 09:08:12 - Newser
Does Harmony Biosciences Holdings Inc. fit your quant trading model2025 Technical Patterns & Free Community Consensus Stock Picks - Newser
Real time social sentiment graph for Harmony Biosciences Holdings Inc.Day Trade & Daily Profit Maximizing Tips - Newser
Will Harmony Biosciences Holdings Inc. bounce back from current supportWeekly Trend Summary & Free Technical Confirmation Trade Alerts - Newser
Visual analytics tools that track Harmony Biosciences Holdings Inc. performanceJuly 2025 Momentum & Accurate Technical Buy Alerts - Newser
Using RSI to spot recovery in Harmony Biosciences Holdings Inc.Weekly Market Report & Daily Profit Maximizing Trade Tips - Newser
Is Harmony Biosciences Holdings Inc. building a consolidation baseWeekly Trade Analysis & Consistent Income Trade Ideas - Newser
What MACD and RSI say about Harmony Biosciences Holdings Inc.Volume Spike & Fast Exit Strategy with Risk Control - Newser
Key metrics from Harmony Biosciences Holdings Inc.’s quarterly dataJuly 2025 Spike Watch & Daily Market Momentum Tracking - Newser
Harmony Biosciences Holdings Inc. stock volume spike explainedJuly 2025 Summary & High Conviction Buy Zone Alerts - Newser
Visual trend scoring systems applied to Harmony Biosciences Holdings Inc.2025 Risk Factors & Smart Money Movement Alerts - Newser
Applying big data sentiment scoring on Harmony Biosciences Holdings Inc.Market Sentiment Report & Real-Time Buy Signal Notifications - Newser
How sentiment analysis helps forecast Harmony Biosciences Holdings Inc.Fed Meeting & Fast Gain Stock Tips - Newser
Tools to assess Harmony Biosciences Holdings Inc.’s risk profileShare Buyback & Verified Trade Idea Suggestions - Newser
Does Harmony Biosciences Holdings Inc. offer margin of safetyPortfolio Value Report & Verified Momentum Stock Watchlist - khodrobank.com
Signal strength of Harmony Biosciences Holdings Inc. stock in tech scanners2025 EndofYear Setup & Safe Entry Zone Tips - Newser
What is Harmony Biosciences Holdings Inc.’s valuation compared to sector2025 Support & Resistance & Technical Pattern Recognition Alerts - khodrobank.com
Custom strategy builders for tracking Harmony Biosciences Holdings Inc. - Newser
Is Harmony Biosciences Holdings Inc. a top pick in the sectorMarket Activity Report & Capital Protection Trade Alerts - khodrobank.com
Is Harmony Biosciences Holdings Inc. in accumulation or distribution phase2025 Short Interest & Precise Trade Entry Recommendations - khodrobank.com
Market Outlook: What’s the outlook for Harmony Biosciences Holdings Inc.’s sectorWeekly Stock Report & High Accuracy Trade Signal Alerts - khodrobank.com
Historical volatility pattern of Harmony Biosciences Holdings Inc. visualizedShare Buyback & Capital Protection Trading Alerts - Newser
Backtesting results for Harmony Biosciences Holdings Inc. trading strategies2025 Trading Recap & AI Driven Price Predictions - Newser
What candlestick patterns are forming on Harmony Biosciences Holdings Inc.Weekly Profit Summary & Community Verified Watchlist Alerts - Newser
Harmony Biosciences Holdings Inc. stock outlook for YEARJuly 2025 Intraday Action & AI Enhanced Market Trend Forecasts - Newser
How to recover losses in Harmony Biosciences Holdings Inc. stock2025 Buyback Activity & Daily Profit Focused Screening - Newser
Is Harmony Biosciences Holdings Inc. stock reversal real or fakeJuly 2025 Earnings & Safe Capital Growth Tips - Newser
Analyzing Harmony Biosciences Holdings Inc. with risk reward ratio charts2025 Market Overview & Consistent Income Trade Ideas - Newser
Momentum divergence signals in Harmony Biosciences Holdings Inc. chartSwing Trade & Fast Gain Stock Tips - Newser
Predicting Harmony Biosciences Holdings Inc. trend using moving averagesWeekly Volume Report & Free Community Consensus Stock Picks - Newser
하모니 바이오 (HRMY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.14%
1.34%
자본화:
|
볼륨(24시간):